Lung adenocarcinoma biomarker incidence in hispanic versus non-hispanic white patients Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Biomarkers, Tumor
  • Lung Neoplasms

abstract

  • Targetable biomarkers other than EGFR and EML4-ALK were identified in 7 of the 40 Hispanic patients (18%) and 5 of the 43 non-Hispanic white patients (12%), suggesting a similar mutational frequency. Our highly multiplexed genotyping assay detected actionable mutations in 14% (12 of 83) more patients than would have been identified by EGFR and EML4-ALK testing alone.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.5858/arpa.2013-0225-OA

PubMed ID

  • 23802852

Additional Document Info

start page

  • 390

end page

  • 4

volume

  • 138

number

  • 3